tiprankstipranks
Trending News
More News >
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
US Market

Bolt Biotherapeutics (BOLT) Ownership - Who Owns Bolt Biotherapeutics?

Compare
240 Followers

Bolt Biotherapeutics (BOLT) Ownership Overview

2.28%5.10%26.26%0.37%65.99%
26.26% Other Institutional Investors
0.37% ETFs
65.99% Public Companies and
Individual Investors
The ownership structure of Bolt Biotherapeutics (BOLT) stock is a mix of institutional, retail, and individual investors. Approximately 31.73% of the company’s stock is owned by Institutional Investors, 2.28% is owned by Insiders, and 65.99% is owned by Public Companies and Individual Investors.
The ownership structure of Bolt Biotherapeutics (BOLT) stock is a mix of institutional, retail, and individual investors. Approximately 31.36% of the company’s stock is owned by Institutional Investors, 2.28% is owned by Insiders, and 0.37% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
50,695Institution2.64%236,746
38,918Insider2.03%181,747
30,357Institution1.58%141,767
14,117Institution0.74%65,926
7,060Institution0.37%32,970
2,700Institution0.14%12,609
2,313Insider0.12%10,802
1,415Insider0.07%6,608
1,200Insider0.06%5,604

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
50,695Institution2.64%236,746
30,357Institution1.58%141,767
14,117Institution0.74%65,926
2,700Institution0.14%12,609

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,060Institution0.37%41,513

FAQ

Who Owns Bolt Biotherapeutics (BOLT)?
According to the latest TipRanks data, approximately 26.26% of the company's stock is held by institutional investors, 2.28% is held by insiders, and 65.99% is held by retail investors.
    What percentage of Bolt Biotherapeutics (BOLT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 26.26% of Bolt Biotherapeutics (BOLT) stock is held by institutional investors.
      What percentage of Bolt Biotherapeutics (BOLT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 65.99% of Bolt Biotherapeutics (BOLT) stock is held by retail investors.
        Who owns the most shares of Bolt Biotherapeutics (BOLT)?
        Fidelity Commonwealth Trust II owns the most shares of Bolt Biotherapeutics (BOLT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.